IFP Advisors’s Japer Therapeutics Warrants JSPRW Stock Holding History

IFP Advisors’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	50	–	–	﹤0.01%	5123
2026 Q1	$1	Hold	50	–	–	﹤0.01%	5012
2025 Q4	$2	Hold	50	–	–	﹤0.01%	4871
2025 Q3	$4	Hold	50	–	–	﹤0.01%	4810
2025 Q2	$4	Buy	+50	New	+$5	﹤0.01%	4888

Other funds holding JSPRW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

IFP Advisors's JSPRW Position: Q2 2026 in Review

IFP Advisors held its Japer Therapeutics Warrants (JSPRW) position steady in Q2 2026 at 50 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5123.

IFP Advisors first reported a position in JSPRW in Q2 2025 and has held it in 5 quarters since. The position peaked at $4 in Q3 2025. 6 funds tracked by Wall St. Rank hold JSPRW as of Q2 2026.

IFP Advisors held 50 shares of Japer Therapeutics Warrants worth $1 as of Q2 2026.
IFP Advisors left its Japer Therapeutics Warrants share count unchanged in Q2 2026.
Japer Therapeutics Warrants made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5123 holding.
IFP Advisors first reported a position in Japer Therapeutics Warrants in Q2 2025 and has held it in 5 quarters since.
IFP Advisors's Japer Therapeutics Warrants position peaked at $4 in Q3 2025.
6 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.